Question 1

What is the catalog number for SLC39A8 Knockout Cell Line-THP-1?

Accepted Answer

The catalog number for SLC39A8 Knockout Cell Line-THP-1 is RK-0509.

Question 2

What sizes are available for SLC39A8 Knockout Cell Line-THP-1?

Accepted Answer

SLC39A8 Knockout Cell Line-THP-1 is available in the following size(s): 1x 10^6.

Question 3

Is SLC39A8 Knockout Cell Line-THP-1 in stock?

Accepted Answer

SLC39A8 Knockout Cell Line-THP-1 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Are there any special shipping requirements for SLC39A8 Knockout Cell Line-THP-1?

Accepted Answer

SLC39A8 Knockout Cell Line-THP-1 is requires dry ice shipping.

Question 5

Does this product need any special customs documentation to be imported to my country?

Accepted Answer

If you’re outside the EU, UK, or USA, you’re responsible for customs clearance and any related taxes or fees. We provide the standard import documents, such as the Commercial Invoice, Packing List, and Airway Bill, in advance, so let us know early if your customs office needs anything additional for this specific product.

Question 6

What buffer is this product supplied in?

Accepted Answer

The formulation or storage buffer is listed on the product datasheet. If you require a carrier-free or custom formulation, contact us before ordering, as this may involve a made-to-order production timeline.

Question 7

What dilution range is recommended for immunohistochemistry (IHC) with this antibody?

Accepted Answer

A starting IHC dilution range is listed on the datasheet, but should be optimized for your specific tissue type and staining protocol.

SLC39A8 Knockout Cell Line-THP-1

Product Specifications

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Ethyl Propargylate-13C3

CD20 antibody (Spectral Red)

DYKDDDDK Tag (DYKDDDDK) Antibody

DYKDDDDK Tag (DYKDDDDK) Antibody

DYKDDDDK Tag (DYKDDDDK) Antibody

BBS4 (Bardet-Biedl Syndrome 4 Protein) (MaxLight 405) discontinued